SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-24-007124
Filing Date
2024-09-16
Accepted
2024-09-16 16:40:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3547
  Complete submission text file 0001950047-24-007124.txt   5028
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Subject) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39634 | Film No.: 241301612
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O FOGHORN THERAPEUTICS INC. 500 TECHNOLOGY SQUARE, SUITE 700 CAMBRIDGE MA 02139
Business Address
Costa Carlos (Reporting) CIK: 0001939167 (see all company filings)

Type: 144